GO:1990115 RNA polymerase III assembly: Components, Assembly and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:1990115 (RNA polymerase III assembly) describes the aggregation, arrangement and bonding together of components to form the eukaryotic RNA polymerase III (Pol III) complex.
Pol III assembly is a multistep process that may begin co-translationally, with subunit folding and interaction coupled to translation.
The process is tightly linked to cell cycle progression, ensuring that Pol III levels match cellular demand for tRNA and other small RNAs.
Mutations in Pol III subunits, such as POLR3B R103H, impair complex assembly and cause hypomyelinating leukodystrophy; the drug riluzole can partially restore assembly.
TFIIIC acts as both an assembly factor and a barrier in Pol III transcription, influencing how the complex forms and functions.
Studying Pol III assembly requires integrating structural, biochemical, and genetic approaches, including CRISPR-based models and advanced imaging [2,6,8].

Description

RNA polymerase III (Pol III) is the enzyme responsible for transcribing small non-coding RNAs, including tRNAs, 5S rRNA, and U6 snRNA, which are essential for protein synthesis and RNA processing. The assembly of this multi-subunit complex, termed RNA polymerase III assembly (GO:1990115), is a fundamental biological process that ensures the proper formation of the enzyme from its individual subunits. Understanding how Pol III assembles is critical because defects in this process can lead to severe human diseases, including leukodystrophies and cancer. Recent studies have begun to uncover the molecular details of Pol III assembly, revealing a putative co-translational mechanism and intricate regulation by cell cycle and signaling pathways [1,7]. This article provides a comprehensive overview of GO:1990115, integrating authoritative QuickGO data with verified PubMed literature to support researchers in the field.

RNA polymerase III assembly At A Glance

GO ID GO:1990115
GO term RNA polymerase III assembly
Ontology biological_process
Synonym DNA-directed RNA polymerase III complex assembly; RNA Polymerase III complex assembly
Major function Formation of the multi-subunit RNA polymerase III complex
Related cellular component RNA polymerase III complex
Related molecular function DNA-directed 5'-3' RNA polymerase activity
Process regulation Coupled to cell cycle progression and potentially co-translational [1,7]

What Is GO:1990115?

RNA polymerase III assembly (GO:1990115) is the biological process in which a set of protein components aggregate, arrange, and bond together to form the eukaryotic RNA polymerase III complex. This process involves the ordered association of multiple subunits, potentially starting co-translationally, and is essential for the production of functional Pol III enzyme capable of transcribing small RNAs.

Why Is RNA polymerase III assembly Important in Cell Biology?

RNA polymerase III assembly is essential for the production of the Pol III enzyme, which transcribes tRNAs, 5S rRNA, and other small RNAs required for protein synthesis and cellular regulation. Defects in this assembly process are linked to severe human disorders, including hypomyelinating leukodystrophy and cancer, making it a critical area of research. Moreover, understanding Pol III assembly provides insights into fundamental mechanisms of gene expression and offers potential therapeutic targets.
Ensures the formation of functional RNA polymerase III, which is required for transcription of tRNAs and other small RNAs.
Mutations in Pol III subunits that impair assembly cause hypomyelinating leukodystrophy.
Pol III assembly is coupled to cell cycle progression, linking growth signals to transcriptional capacity.
TFIIIC acts as an assembly factor and barrier, influencing Pol III complex formation and function.
Dysregulation of Pol III assembly can contribute to cancer through altered small RNA production.
The process may occur co-translationally, providing a paradigm for multi-subunit complex assembly.
Understanding assembly mechanisms can guide therapeutic strategies for Pol III-related diseases.
Advanced structural studies reveal how subunits interact during assembly [2,6].
Pol III assembly is a target for drug discovery, as shown by riluzole's effect on mutant Pol III.
Research on Pol III assembly benefits from CRISPR-based models to dissect gene function.

What Happens During RNA polymerase III assembly?

Co-translational assembly of Pol III subunits
In simple terms: Parts of the RNA polymerase III machine may be put together while they are still being made.
A putative co-translational mechanism has been proposed for RNA polymerase III assembly, where subunit folding and interaction occur concurrently with translation. This model suggests that the assembly process begins as soon as subunits emerge from the ribosome, ensuring efficient complex formation and preventing aggregation of unassembled subunits.
Cell cycle-coupled assembly
In simple terms: The assembly of RNA polymerase III is timed with the cell's cycle to match growth needs.
In Saccharomyces cerevisiae, RNA polymerase III assembly is coupled to cell cycle progression, with assembly occurring at specific phases to ensure adequate enzyme levels for tRNA synthesis during growth. This coupling ensures that Pol III complex formation is coordinated with cellular demand for protein synthesis.
Role of TFIIIC as an assembly factor
In simple terms: TFIIIC helps build RNA polymerase III and also acts as a checkpoint.
TFIIIC functions not only in transcription initiation but also as an assembly factor and barrier in RNA polymerase III transcription, influencing the formation and stability of the Pol III complex. Its dual role highlights the intricate regulation of Pol III assembly and its integration with transcription.
Structural insights into Pol III assembly
In simple terms: Detailed 3D structures show how the parts of RNA polymerase III fit together.
Recent structural studies have provided high-resolution views of the human RNA polymerase III complex, revealing the architecture and subunit interactions that underlie its assembly. Additionally, the structural basis of TFIIIC-dependent Pol III transcription initiation has been elucidated, offering insights into how assembly interfaces with initiation.
Assembly defects and restoration
In simple terms: When assembly goes wrong, drugs can sometimes fix it.
The leukodystrophy-causative variant POLR3B R103H impairs RNA polymerase III complex assembly, but the drug riluzole can partially restore assembly in cells expressing this mutant. This demonstrates that assembly defects are potentially reversible and can be targeted therapeutically.

Key Genes Involved in GO:1990115 RNA polymerase III assembly

The following genes encode subunits and factors critical for RNA polymerase III assembly, as supported by published literature.
GeneMajor RoleResearch Relevance
POLR3ACore subunit of RNA polymerase IIIMutations cause leukodystrophy; assembly studies
POLR3BCore subunit; R103H variant impairs assemblyModel for assembly defects and drug rescue
POLR3CSubunit of Pol IIIStructural and assembly studies
POLR3DSubunit of Pol IIIStructural and assembly studies
POLR3ESubunit of Pol IIIStructural and assembly studies
POLR3FSubunit of Pol IIIStructural and assembly studies
POLR3GSubunit of Pol IIIStructural and assembly studies
POLR3HSubunit of Pol IIIStructural and assembly studies
POLR3KSubunit of Pol IIIStructural and assembly studies
POLR1CShared subunit with Pol IAssembly and disease links
POLR2EShared subunit with Pol IIAssembly and disease links
GTF3C1TFIIIC subunit; assembly factorTFIIIC-dependent assembly
GTF3C2TFIIIC subunit; assembly factorTFIIIC-dependent assembly
GTF3C3TFIIIC subunit; assembly factorTFIIIC-dependent assembly
GTF3C4TFIIIC subunit; assembly factorTFIIIC-dependent assembly
GTF3C5TFIIIC subunit; assembly factorTFIIIC-dependent assembly
GTF3C6TFIIIC subunit; assembly factorTFIIIC-dependent assembly
STAT3Regulates Pol III-directed transcription via miR-106a-5p/TP73Signaling control of Pol III

How Is RNA polymerase III assembly Regulated?

RNA polymerase III assembly is regulated at multiple levels. It is coupled to cell cycle progression in yeast, ensuring that assembly occurs when cells are ready for growth. Additionally, TFIIIC acts as both an assembly factor and a barrier, providing a regulatory checkpoint. Signaling pathways, such as STAT3, can promote Pol III-directed transcription by controlling the miR-106a-5p/TP73 axis, indirectly influencing assembly. The putative co-translational mechanism suggests that assembly is also regulated at the level of translation and subunit availability.

RNA polymerase III assembly and Human Disease

GeneDisease / BiologyPotential Experimental Model
POLR3BHypomyelinating leukodystrophyKnock-in of R103H mutation in cell lines
POLR3AHypomyelinating leukodystrophyKnockout or point mutation models
STAT3CancerOverexpression or knockout in cancer cell lines
GTF3C1Potential Pol III-related disordersKnockout or knockdown in cell models
POLR3KLeukodystrophy and other disordersCRISPR knockout in patient-derived cells
Hypomyelinating leukodystrophy
Mutations in POLR3B, such as R103H, impair RNA polymerase III assembly and cause hypomyelinating leukodystrophy, a severe neurological disorder characterized by defective myelin formation. The drug riluzole can partially restore assembly in cells expressing this variant, offering a potential therapeutic avenue.
Cancer
Dysregulation of RNA polymerase III assembly and function can contribute to cancer. STAT3 promotes Pol III-directed transcription by controlling the miR-106a-5p/TP73 axis, linking signaling pathways to Pol III activity in cancer cells. Altered Pol III assembly may thus support oncogenic transformation.
Other Pol III-related disorders
Beyond leukodystrophy, defects in Pol III subunits and assembly factors have been associated with other diseases, though the mechanisms remain under investigation. TFIIIC's role as an assembly factor and barrier suggests that its dysfunction could contribute to disease.

From RNA polymerase III assembly-Related Genes to Experimental Models

Research QuestionSuitable Model
What is the effect of POLR3B R103H on assembly?Knock-in of R103H in HEK293 or patient fibroblasts
How does loss of a Pol III subunit affect assembly?CRISPR knockout of POLR3A in cell lines
Can a drug restore assembly?Overexpression of mutant POLR3B with riluzole treatment
How does TFIIIC contribute to assembly?Knockout of GTF3C1 in cell lines
Is assembly co-translational?Tagged knock-in of Pol III subunits for ribosome profiling
How does STAT3 regulate Pol III?Overexpression or knockout of STAT3 in cancer cells

How to Study the RNA polymerase III assembly Process

MethodWhat It MeasuresTypical Application
Cryo-EM3D structure of Pol III complexUnderstanding subunit interactions
In vitro assembly assayFormation of Pol III complexTesting assembly defects and drug rescue
Cell cycle synchronizationTiming of assemblyStudying cell cycle coupling
Single-fiber imagingChromatin architecture and transcriptionLinking assembly to transcription
Ribosome profilingCo-translational assemblyTesting co-translational mechanism
CRISPR knockoutGene function in assemblyIdentifying essential subunits
ProteomicsSubunit interactionsMapping assembly intermediates
RNA-seqTranscriptional outputAssessing Pol III activity
Structural biology (cryo-EM)
Cryo-electron microscopy has been used to determine the high-resolution structure of human RNA polymerase III, revealing subunit interactions critical for assembly. This method provides detailed insights into the architecture of the complex and how subunits come together.
Biochemical assembly assays
In vitro assembly assays using purified subunits or cell lysates can monitor the formation of the Pol III complex. For example, the effect of the POLR3B R103H variant on assembly was assessed using such assays, showing impaired complex formation that could be partially rescued by riluzole.
Genetic and cell cycle studies
In Saccharomyces cerevisiae, genetic approaches have demonstrated that Pol III assembly is coupled to cell cycle progression, using synchronized cell cultures and conditional mutants. These studies reveal temporal regulation of assembly.
Imaging and single-fiber analysis
Advanced imaging techniques, such as single-fiber analysis, have shown how RNA polymerases reshape chromatin architecture and couple transcription, providing insights into the spatial organization of Pol III assembly and function.

How CRISPR Can Be Used to Study GO:1990115 RNA polymerase III assembly

Knockout

CRISPR knockout of Pol III subunit genes, such as POLR3A or POLR3B, can be used to study their essential roles in assembly and cell viability. Knockout cell lines provide a clean background to test assembly defects and potential rescue strategies.

Point Mutation

CRISPR point mutation can introduce disease-associated variants, such as POLR3B R103H, to model impaired assembly and test drug responses like riluzole. This approach allows precise dissection of assembly mechanisms.

Knock-in

Knock-in of tagged Pol III subunits (e.g., GFP or FLAG) enables visualization and purification of assembly intermediates, facilitating co-translational studies. Tagged knock-in models are valuable for tracking complex formation in live cells.

Overexpression

CRISPR-mediated overexpression of Pol III subunits or assembly factors like TFIIIC can be used to study their effects on assembly and transcription. Overexpression models help identify rate-limiting steps and regulatory mechanisms.

How EDITGENE Supports RNA polymerase III assembly Research

Researchers studying RNA polymerase III assembly-related genes often need to determine whether a candidate gene is causally involved in complex formation, how mutations affect assembly, and whether therapeutic intervention is possible. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions, from knockout to point mutation and overexpression models, supported by advanced screening and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for RNA polymerase III assembly research.

Frequently Asked Questions About RNA polymerase III assembly

RNA polymerase III assembly (GO:1990115) is the process by which the multi-subunit RNA polymerase III complex is formed from its individual protein components.
Genes encoding Pol III subunits such as POLR3A, POLR3B, POLR3C, and assembly factors like GTF3C1 (TFIIIC) are involved [2,4].
It is coupled to cell cycle progression and regulated by TFIIIC and signaling pathways like STAT3 [3,4,7].
Mutations in POLR3B can cause hypomyelinating leukodystrophy, and dysregulation is linked to cancer [3,5].
Riluzole has been shown to partially restore assembly in cells expressing the POLR3B R103H variant.
Cryo-EM, in vitro assembly assays, cell cycle synchronization, and CRISPR-based models are commonly used [2,5,7].
A putative co-translational mechanism has been proposed, where assembly begins as subunits are synthesized.
TFIIIC acts as both an assembly factor and a barrier in Pol III transcription.
STAT3 promotes Pol III-directed transcription by controlling the miR-106a-5p/TP73 axis.
Altered Pol III assembly can support oncogenic transformation by increasing small RNA production.

Conclusion

RNA polymerase III assembly (GO:1990115) is a vital biological process that ensures the formation of the Pol III complex, which is essential for transcribing small RNAs required for protein synthesis and cellular regulation. Defects in this process are linked to severe diseases, including leukodystrophy and cancer, making it a key area of research [3,5]. Advances in structural biology, CRISPR-based models, and biochemical assays continue to unravel the mechanisms of Pol III assembly, offering potential therapeutic targets [1,4,6]. EDITGENE provides comprehensive CRISPR services to support researchers in dissecting this process and developing new treatments.

References

  1. 1. Boguta M. 2022. Assembly of RNA polymerase III complex involves a putative co-translational mechanism.. Gene 824:146394 PMID: 35278633
  2. 2. Ramsay EP et al.. 2020. Structure of human RNA polymerase III.. Nat Commun 11(1):6409 PMID: 33335104
  3. 3. Zhang C et al.. 2023. STAT3 promotes RNA polymerase III-directed transcription by controlling the miR-106a-5p/TP73 axis.. Elife 12 PMID: 36656267
  4. 4. Seifert-Davila W et al.. 2025. Should I stay or should I go: TFIIIC as assembly factor and barrier in RNA polymerase III transcription.. Biochem Soc Trans 53(4):925-934 PMID: 40762516
  5. 5. Pinard M et al.. 2022. Riluzole partially restores RNA polymerase III complex assembly in cells expressing the leukodystrophy-causative variant POLR3B R103H.. Mol Brain 15(1):98 PMID: 36451185
  6. 6. Talyzina A et al.. 2023. Structural basis of TFIIIC-dependent RNA polymerase III transcription initiation.. Mol Cell 83(15):2641-2652.e7 PMID: 37402369
  7. 7. Płonka M et al.. 2019. Coupling of RNA polymerase III assembly to cell cycle progression in Saccharomyces cerevisiae.. Cell Cycle 18(4):500-510 PMID: 30760101
  8. 8. Tullius TW et al.. 2024. RNA polymerases reshape chromatin architecture and couple transcription on individual fibers.. Mol Cell 84(17):3209-3222.e5 PMID: 39191261
Contact Us
*
*
*
*
How did you hear about us: